Drugs that contain Nimodipine

1. Drug name - NYMALIZE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7070581 ARBOR PHARMS LLC Dispenser for medicaments and method and apparatus for making same Jun, 2023

(8 months from now)

US8517997 ARBOR PHARMS LLC Dispenser for medicaments and method and apparatus for making same May, 2024

(1 year, 7 months from now)

US10342787 ARBOR PHARMS LLC Non-aqueous liquid nimodipine compositions Apr, 2038

(15 years from now)

US10576070 ARBOR PHARMS LLC Non-aqueous liquid nimodipine compositions Apr, 2038

(15 years from now)

US11207306 ARBOR PHARMS LLC Non-aqueous liquid nimodipine compositions Apr, 2038

(15 years from now)

Treatment: A method for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry aneurysms

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
3MG/ML SOLUTION;ORAL Discontinued
6MG/ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.